These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

59 related items for PubMed ID: 17306784

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Lymphocyte DNA damage and oxidative stress in patients with iron deficiency anemia.
    Aslan M, Horoz M, Kocyigit A, Ozgonül S, Celik H, Celik M, Erel O.
    Mutat Res; 2006 Oct 10; 601(1-2):144-9. PubMed ID: 16920160
    [Abstract] [Full Text] [Related]

  • 9. The relationship between red-cell distribution width and abnormal left ventricle geometric patterns in patients with untreated essential hypertension.
    Kilicaslan B, Dursun H, Aydin M, Ekmekci C, Ozdogan O.
    Hypertens Res; 2014 Jun 10; 37(6):560-4. PubMed ID: 24599016
    [Abstract] [Full Text] [Related]

  • 10. DNA damage in metabolic syndrome and its association with antioxidative and oxidative measurements.
    Demirbag R, Yilmaz R, Gur M, Celik H, Guzel S, Selek S, Kocyigit A.
    Int J Clin Pract; 2006 Oct 10; 60(10):1187-93. PubMed ID: 16981963
    [Abstract] [Full Text] [Related]

  • 11. DNA damage in children with asthma bronchiale and its association with oxidative and antioxidative measurements.
    Zeyrek D, Cakmak A, Atas A, Kocyigit A, Erel O.
    Pediatr Allergy Immunol; 2009 Jun 10; 20(4):370-6. PubMed ID: 18801009
    [Abstract] [Full Text] [Related]

  • 12. DNA damage and oxidative status in newly diagnosed, untreated, dipper and non-dipper hypertensive patients.
    Gür M, Elbasan Z, Yıldıray Şahin D, Yıldız Koyunsever N, Seker T, Ozaltun B, Caylı M, Kocyigit A.
    Hypertens Res; 2013 Feb 10; 36(2):166-71. PubMed ID: 23096232
    [Abstract] [Full Text] [Related]

  • 13. Relationship between arterial stiffness and myocardial damage in patients with newly diagnosed essential hypertension.
    Gedikli O, Ozturk S, Yilmaz H, Baykan M, Kiris A, Durmus I, Baltaci D, Karahan C, Celik S.
    Am J Hypertens; 2008 Sep 10; 21(9):989-93. PubMed ID: 18617881
    [Abstract] [Full Text] [Related]

  • 14. Oxidative DNA damage and total antioxidant status in rats during experimental gram-negative sepsis.
    Kaymak C, Kadioglu E, Ozcagli E, Osmanoglu G, Izdes S, Agalar C, Basar H, Sardas S.
    Hum Exp Toxicol; 2008 Jun 10; 27(6):485-91. PubMed ID: 18784201
    [Abstract] [Full Text] [Related]

  • 15. Effect of coronary angiography on oxidative DNA damage observed in circulating lymphocytes.
    Demirbag R, Yilmaz R, Kocyigit A, Guzel S.
    Angiology; 2007 Jun 10; 58(2):141-7. PubMed ID: 17495261
    [Abstract] [Full Text] [Related]

  • 16. Excessive increase in left ventricular mass identifies hypertensive subjects with clustered geometric and functional abnormalities.
    Chinali M, De Marco M, D'Addeo G, Benincasa M, Romano C, Galderisi M, de Simone G.
    J Hypertens; 2007 May 10; 25(5):1073-8. PubMed ID: 17414672
    [Abstract] [Full Text] [Related]

  • 17. Increased DNA damage in patients with complete hydatidiform mole.
    Harma M, Harma M, Kocyigit A, Erel O.
    Mutat Res; 2005 May 02; 583(1):49-54. PubMed ID: 15866465
    [Abstract] [Full Text] [Related]

  • 18. Oxidative DNA damage and plasma antioxidant capacity in type 2 diabetic patients with good and poor glycaemic control.
    Lodovici M, Giovannelli L, Pitozzi V, Bigagli E, Bardini G, Rotella CM.
    Mutat Res; 2008 Feb 01; 638(1-2):98-102. PubMed ID: 17964614
    [Abstract] [Full Text] [Related]

  • 19. Association between the morning-evening difference in home blood pressure and cardiac damage in untreated hypertensive patients.
    Matsui Y, Eguchi K, Shibasaki S, Shimizu M, Ishikawa J, Shimada K, Kario K.
    J Hypertens; 2009 Apr 01; 27(4):712-20. PubMed ID: 19516171
    [Abstract] [Full Text] [Related]

  • 20. Left ventricular (LV) geometry and dipping state are determinants of LV mass reduction with angiotensin-converting enzyme inhibitor antihypertensive treatment.
    Aznaouridis KA, Vyssoulis GP, Karpanou EA, Marinakis AG, Barbetseas JD, Zervoudaki AI, Cokkinos DV, Stefanadis CI.
    Blood Press Monit; 2007 Apr 01; 12(2):87-94. PubMed ID: 17353651
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.